Daniel C. Peltier
助理教授
Division of Hematology/Oncology
Department of Pediatrics, Indiana University School of Medicine;Melvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine;Herman B Wells Center for Pediatric Research, Indiana University School of Medicine;Riley Hospital for Children
关注
立即认领
分享
关注
立即认领
分享
基本信息
浏览量:0
职业迁徙
个人简介
Clinically, he cares for children undergoing HSCT or receiving cellular therapies for malignant or non-malignant conditions. He has a particular clinical interest in caring for children experiencing a complication of HSCT call graft-versus-host disease. Scientifically, he studies how a new class of genes called long noncoding RNAs regulates immunity. He is especially interested in how long noncoding RNAs regulate cellular therapies and the immune response that causes graft-versus-host-disease. The goal of these studies is to find new ways of enhancing the safety of HSCT and cellular therapies by improving the diagnosis, prevention, or treatment of complications from HSCT and cellular therapies.
研究兴趣
论文共 33 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Transplantation and Cellular Therapyno. 2 (2023): S60-S60
Masahiro Miyata,Eri Matsuki,Kazunobu Ichikawa, Tomohiro Takehara, Yuka Hosokawa,Erika Sekiguchi,Daniel Peltier,Pavan Reddy,Kenichi Ishizawa,Masafumi Watanabe,Tomomi Toubai
Blood advancesno. 22 (2023): 6936-6948
SSRN Electronic Journalno. 9 (2022): 104846
Daniel Peltier,Molly Radosevich,Visweswaran Ravikumar,Sethuramasundaram Pitchiaya, Thomas Decoville,Sherri C. Wood,Guoqing Hou,Cynthia Zajac,Katherine Oravecz-Wilson, David Sokol,Israel Henig,Julia Wu,
Science translational medicineno. 585 (2021)
Daniel Peltier,Sethuramasundaram Pitchiaya,Visweswaran Ravikumar, Thomas Decoville, Sherri Wood,Katherine Oravecz-Wilson,Yaping Sun,Arvind Rao,Arul Chinnaiyan,Daniel Goldstein,Pavan Reddy
Transplantation and Cellular Therapyno. 3 (2021)
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn